Returning to Everyday Tasks Utilizing Rehabilitation Networks-III (RETURN-III)
NCT ID: NCT04353804
Last Updated: 2025-02-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE2
160 participants
INTERVENTIONAL
2022-10-03
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Pilot Study of Rehabilitation Among Intensive Care Unit (ICU) Survivors: the RETURN Trial
NCT00715494
ACT-ICU Study: Activity and Cognitive Therapy in the Intensive Care Unit
NCT01270269
Virtual Reality Rehabilitation in Patients With Acquired Brain Injury
NCT03402360
Telerehabilitation Through Serious Games in Virtual Reality in a Stroke Population (AutoRReVi)
NCT04694833
Home-based Virtual Reality Training After Stroke
NCT03261713
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Data from the investigators' group and others show that 50% of ICU survivors suffer from ICU-LTCI. The investigators' Veterans Affairs (VA) Merit Award funded research, "Measuring the Incidence and determining risk factors for Neuropsychological Dysfunction in ICU Survivors" (MIND-ICU) study, helped define the epidemiology of this persistent and progressive chronic brain dysfunction that affects both executive function and memory domains of cognition. Among survivors from medical and surgical ICUs, 40% have impairments rivaling moderate traumatic brain injury, and 30% have impairments similar to mild-moderate Alzheimer's disease. The MIND-ICU study indicates that the number of Veterans who develop ICU-LTCI is as high as the number of new traumatic brain injury diagnoses among all Active Duty, National Guard, and Reserves of the Army, Navy, Air Force and Marine Corps. For a public health problem of this magnitude, there is a driving unmet need to find solutions for ICU-LTCI.
The investigators' pilot randomized "Returning to Everyday Tasks Utilizing Rehabilitation Networks-I" (RETURN-I) Study showed that a 12-week cognitive rehabilitation intervention (vs. controls) improved executive dysfunction. Next, the investigators transformed this non-computerized, resource-intensive strategy into a novel, efficient, and scalable Computerized Cognitive Rehabilitation (CCR) method. This plasticity-based adaptive CCR was applied to a case-series of ICU survivors which signaled improvements across multiple cognitive domains.
Building on nearly two decades of aging brain research with the VA-Tennessee Valley Geriatric Research, Education and Clinical Center (GRECC), the investigators now propose a Phase II randomized controlled trial (RCT) to investigate the efficacy of CCR for survivors with ICU-LTCI. The Returning to Everyday Tasks Utilizing Rehabilitation Networks-III Study (RETURN-III Study) will be the next logical data-driven approach to develop and offer innovative real-world solutions for civilians and Veterans surviving critical illness with disabling ICU-LTCI.
To test these hypotheses, the RETURN-III study will randomize medical and surgical VA ICU survivors to either intervention using CCR, or control of non-specific computer games. At three, and twelve months post-randomization, trained research personnel blinded to group assignment will use a validated battery to assess global cognition \[primary outcome\].
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Computerized Cognitive Rehabilitation
Computerized Cognitive Rehabilitation
Treatment Arm: Computerized Cognitive Rehabilitation
Treatment Arm: Computerized Cognitive Rehabilitation
Active Control computer games
Active Control computer games
Active Control computer games
Active Control computer games
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Treatment Arm: Computerized Cognitive Rehabilitation
Treatment Arm: Computerized Cognitive Rehabilitation
Active Control computer games
Active Control computer games
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No longer requiring ICU-level care
Exclusion Criteria
* Unwilling to commit to participation in the intervention
* Under consideration for hospice
* Primary residence over 100 miles from enrolling site if the patient is unwilling to return to the enrolling site for follow-up
* Homeless without a secondary contact available
* Severe substance abuse or neuropsychiatric disorder of a severity that prevents independent living
* Active suicidal ideation
* Any past or present behavior that may be deemed a safety risk for follow-up
* Blind, deaf, or unable to understand/communicate in English
* Required ICU level care less than 24 hours
* Not capable of completing computer-based training
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vanderbilt University Medical Center
OTHER
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
E. Wesley Ely, MD MPH
Role: PRINCIPAL_INVESTIGATOR
Tennessee Valley Healthcare System Nashville Campus, Nashville, TN
Mayur B Patel, MD MPH
Role: PRINCIPAL_INVESTIGATOR
Tennessee Valley Healthcare System Nashville Campus, Nashville, TN
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tennessee Valley Healthcare System Nashville Campus, Nashville, TN
Nashville, Tennessee, United States
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1506673-1
Identifier Type: OTHER
Identifier Source: secondary_id
230960
Identifier Type: OTHER
Identifier Source: secondary_id
D2992-R
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.